Medicare/Medicaid Insurance Status Is Associated With Reduced Lower Bilateral Knee Arthroplasty Utilization and Higher Complication Rates.


Journal

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews
ISSN: 2474-7661
Titre abrégé: J Am Acad Orthop Surg Glob Res Rev
Pays: United States
ID NLM: 101724868

Informations de publication

Date de publication:
01 04 2022
Historique:
received: 13 01 2021
accepted: 23 01 2022
entrez: 26 4 2022
pubmed: 27 4 2022
medline: 29 4 2022
Statut: epublish

Résumé

Whether to undergo bilateral total knee arthroplasty (BTKA) depends on patient and surgeon preferences. We used the National Inpatient Sample to compare temporal trends in BTKA utilization and in-hospital complication rates among TKA patients ≥50 with Medicare/Medicaid versus private insurance from 2007 to 2016. We used multivariable logistic regression to assess the association between insurance type and trends in utilization and complication rates adjusting for individual-, hospital-, and community-level covariates, using unilateral TKA (UTKA) for reference. Discharge weights were used for nationwide estimates. About 132,400 (49.5%) Medicare/Medicaid patients and 135,046 (50.5%) privately insured patients underwent BTKA. Among UTKA patients, 62.7% had Medicare/Medicaid, and 37.3% had private insurance. Over the study period, BTKA utilization rate decreased from 7.18% to 5.63% among privately insured patients and from 4.59% to 3.13% among Medicaid/Medicare patients (P trend difference <0.0001). In multivariable analysis, Medicare/Medicaid patients were less likely to receive BTKA than privately insured patients. Although Medicare/Medicaid patients were more likely to develop in-hospital complications after UTKA (adjusted odds ratio, 1.06; 95% confidence interval, 1.002 to 1.12; P = 0.04), this relationship was not statistically significant for BTKAs. In this nationwide sample of TKA patients, BTKA utilization rate was higher in privately insured patients compared with Medicare/Medicaid patients. Furthermore, privately insured patients had lower in-hospital complication rates than Medicare/Medicaid patients.

Identifiants

pubmed: 35472007
doi: 10.5435/JAAOSGlobal-D-21-00016
pii: 01979360-202204000-00022
pmc: PMC10566829
pii:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAMS NIH HHS
ID : K24 AR055259
Pays : United States

Informations de copyright

Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Orthopaedic Surgeons.

Références

J Eval Clin Pract. 2012 Jun;18(3):555-9
pubmed: 21223460
J Arthroplasty. 2015 Nov;30(11):1887-91
pubmed: 26093485
J Arthroplasty. 2020 Feb;35(2):401-406
pubmed: 31635904
Health Aff (Millwood). 2008 Nov-Dec;27(6):1587-98
pubmed: 18997215
J Arthroplasty. 2012 Dec;27(10):1761-1765.e1
pubmed: 22868072
J Bone Joint Surg Am. 2007 Jun;89(6):1220-6
pubmed: 17545424
J Arthroplasty. 2021 Apr;36(4):1310-1317
pubmed: 33234385
J Arthroplasty. 2016 Sep;31(9 Suppl):212-6
pubmed: 27430183
Health Equity. 2019 Dec 16;3(1):628-636
pubmed: 31872168
J Bone Joint Surg Am. 2016 Aug 3;98(15):1243-52
pubmed: 27489314
J Arthroplasty. 2020 May;35(5):1174-1178
pubmed: 31924490
J Knee Surg. 2013 Aug;26(4):273-9
pubmed: 23283634
J Arthroplasty. 2003 Jan;18(1):29-34
pubmed: 12555179
J Arthroplasty. 1998 Feb;13(2):172-9
pubmed: 9526210
J Arthroplasty. 2019 Jul;34(7):1531-1537
pubmed: 31031158
Arthritis Rheum. 2005 Dec 15;53(6):979-81
pubmed: 16342110
Anesthesiology. 2009 Dec;111(6):1206-16
pubmed: 19934863
J Bone Joint Surg Am. 2013 Aug 21;95(16):1441-9
pubmed: 23965693
Arthroplast Today. 2019 May 30;5(2):251-255
pubmed: 31286052
J Arthroplasty. 2014 Feb;29(2):295-8
pubmed: 23927908
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
J Arthroplasty. 2009 Dec;24(8):1174-7
pubmed: 19056233
J Arthroplasty. 2013 Aug;28(7):1141-7
pubmed: 23518424
Arthroplast Today. 2020 Jun 23;6(3):437-444
pubmed: 32613050

Auteurs

Bella Mehta (B)

From the Department of Medicine, Hospital for Special Surgery, New York, NY (Dr. Mehta, Dr. Russell, and Dr. Goodman); the Department of Medicine (Dr. Mehta, Dr. Memtsoudis, Dr. Parks, Dr. Russell, and Dr. Goodman), and the Department of Population Health Sciences (Dr. Ho), Weill Cornell Medicine, New York, NY; the Department of Orthopedics (Dr. Bido and Dr. Parks), and the Department of Anesthesiology (Dr. Memtsoudis), Hospital for Special Surgery, New York, NY; and the Department of Healthcare Policy & Research, Weill Cornell Medicine, New York, NY (Dr. Ibrahim).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH